Navigation Links
INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
Date:10/13/2007

monotherapy phase (primary endpoint) followed by a four-week additive therapy phase (secondary endpoint). During the four-week phase, patients could be prescribed additional psychotropic therapy as clinically indicated to manage psychiatric symptoms.

Recent trials in hospitalized patients have suggested the need for higher doses in the treatment of acute patients(2). This study examined the effects of recommended labeled doses while taking into account common clinical practice for this patient population. INVEGA was initiated at the recommended starting dose of 6mg/day (days one to three) increasing to 9 mg/day on day four. As these patients were acutely ill, there was an option to increase the dose to 12 mg/day on day eight. SEROQUEL was titrated to 600 mg/day by day five with an option to increase the dose to 800 mg/day on day eight. Because this study enrolled severely ill patients with recent onset of symptoms, patients were more likely to require doses near the upper end of the recommended ranges to control their symptoms. The average doses during the monotherapy phase were 10.4 mg/day for INVEGA and 690.9 mg/day for SEROQUEL.

The primary efficacy endpoint was total change in PANSS score from baseline to the end of the monotherapy phase (day 14). The average PANSS score at baseline was 102.8 (plus or minus 13.1) for the INVEGA group, 101.6 (plus or minus 13.5) for the SEROQUEL group, and 103.8 (plus or minus 15.7) for the placebo group. At the end of the monotherapy phase (day 14), the change in the total score from baseline was: -23.4 (1.8) for INVEGA, - 17.1(1.8) for SEROQUEL and -15.0 (2.2) for placebo, with INVEGA showing a significant reduction in symptoms over both SEROQUEL (p < less than > 0.001) and placebo (p < less than > 0.001).

In a separate analysis, INVEGA(TM) also produced a statistically significant improvement in the reduction in the individual symptom domains of the PANSS, which includes positive symptoms, negative symptoms,
'/>"/>

SOURCE Janssen, L.P. and Johnson & Johnson
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
6. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
7. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
8. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
9. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
10. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
11. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  Smile Train and its ... showcase their Virtual Surgery Simulator among leading global health ... take place in Washington, D.C. ... Arts. "Smile Train is honored to ... talented community of innovators in health and medicine that ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... MEXICO CITY , July 25, 2014 IBM ... Latin American healthcare sciences publisher, launched a library of ... conditions such as cancer and heart disease. Healthcare providers ... up-to-date information to deliver better patient care. ... with many relying on smartphones and tablets to access ...
Breaking Medicine Technology:Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4
... at Leading Urology Meeting Show that Simple Urine Test ... Detection, Reduce Unnecessary Biopsies -- Gen-Probe to Begin Pivotal ... -SAN DIEGO, April 29 Eight studies presented this ... Association (AUA) suggest that Gen-Probe,s (Nasdaq: GPRO ...
... WASHINGTON, April 29 The recent announcement of the REDUCE ... Chicago brings optimism to the prostate cancer community as dutasteride ... shown to lower by 23 percent the risk of prostate ... Men,s Health Network looks forward to this becoming an additional ...
Cached Medicine Technology:Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 2Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 3Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 4Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 5Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer 2
(Date:7/26/2014)... WA (PRWEB) July 26, 2014 “Healthy teeth ... in keeping those pearly whites shining,” says Community Health Center ... Teeth Healthy ." , They believe that an integration of ... people healthy and well. Because of this, they encourage regular ... also with dentist . , “Children and adults will ...
(Date:7/26/2014)... July 26, 2014 Multiple sclerosis ... disseminata, is an inflammatory disease in which the ... and spinal cord are damaged. This damage disrupts ... to communicate, resulting in a wide range of ... psychiatric problems. Multiple sclerosis takes several forms, with ...
(Date:7/26/2014)... OH (PRWEB) July 26, 2014 The U.S. ... guidelines list that includes a new medication guide for AndroGel ... a serious side-effect of taking the topical low testosterone medication, ... that AbbVie Inc., the makers of the low testosterone theapy ... symptoms of pain, swelling or redness as signs of a ...
(Date:7/26/2014)... Louisville, Kentucky (PRWEB) July 26, 2014 ... concussions on the playing field; however, concussions ... on-the-job injuries. The occupations with the highest risk ... workers ,     Firefighters ,     Police officers ... dock workers ,     Delivery personnel ...
(Date:7/26/2014)... According to the Banish My Bumps ... comprehensive guide that covers detailed instructions on how to ... need of any medication. , Vkool reveals in ... safe remedies for relieving symptoms of keratosis pilaris quickly. ...     How to treat children's keratosis pilaris , ...
Breaking Medicine News(10 mins):Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3
... oral use of RU-486,s companion drug misoprostol is safe, but ... use of a drug given with RU-486 to terminate a ... infections seen in women taking the drugs since 2000, a ... drug misoprostol is FDA-approved to be taken by mouth along ...
... awarded to IDC in ... Pakistan, ... the global leader in the rapidly growing market for,digital radiography, today announced ... Pakistan to install the X-Series 2200,digital radiography (DR) systems in eight A-Class ...
... Clinica - the world,s leading news,service for the medical ... London,s Houses of Parliament have been at risk of ... during the,last three years. This news comes despite warnings ... Parliamentary assurances that the material,discovered in 2005 was safely ...
... Plan honored for service, strategic excellence by federal program, ... today,that the Blue Cross and Blue Shield Association has ... as well as to eight other,affiliated Blue plans., ... 2007 Best of,Blue FEP Plan Excellence winners at its ...
... showed similarities between lesbians, straight men , , MONDAY, June 16 ... remarkable similarities between the brains of gay men and straight ... For example, the brains of straight men and of gay ... the right hemisphere larger than the left, say the Swedish ...
... noninvasive molecular imaging technology, a method has been developed ... cells (MSCs) in the tumors of living organisms, according ... could lead to major advances in the use of ... cancer therapies are still in the early stages of ...
Cached Medicine News:Health News:Abortion drug's off-label use may have led to deaths 2Health News:Abortion drug's off-label use may have led to deaths 3Health News:IDC implements DR systems in eight A-Class military hospitals in Pakistan 2Health News:IDC implements DR systems in eight A-Class military hospitals in Pakistan 3Health News:Palace of Westminster Asbestos Problem Ignored 2Health News:Gay Men, Straight Women Have Similar Brains 2Health News:Gay Men, Straight Women Have Similar Brains 3Health News:Ability to track stem cells in tumors could advance cancer treatments 2Health News:Ability to track stem cells in tumors could advance cancer treatments 3
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
For the quantitative colorimetric determination of AST (SGOT) in serum....
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
... The stainer TST 44 is an ... needed in histology and cytology laboratories. It ... short time. Its again increased large number ... continuous working principle provides a high throughput. ...
Medicine Products: